Structure Therapeutics
GPCR
GPCR
166 hedge funds and large institutions have $2.33B invested in Structure Therapeutics in 2024 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 63 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
25% more capital invested
Capital invested by funds: $1.86B → $2.33B (+$465M)
3.42% more ownership
Funds ownership: 31.22% → 34.64% (+3.4%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
166
Holding in Top 10
4
Calls
$53.3M
Puts
$25.1M
Top Buyers
| 1 | +$110M | |
| 2 | +$67.6M | |
| 3 | +$65.8M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$63M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$50.1M |
Top Sellers
| 1 | -$35.5M | |
| 2 | -$30.9M | |
| 3 | -$27M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$23.3M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$20.4M |